One ml contains 2 mg doxorubicin hydrochloride in a pegylated liposomal formulation.
Doxorubicin hydrochloride liposome Injection is a liposome formulation, is doxorubicin hydrochloride encapsulated in liposomes with surface-bound methoxypolyethylene glycol (MPEG). This process is known as pegylation and protects liposomes from detection by the mononuclear phagocyte system (MPS), which increases blood circulation time.
Excipients/Inactive Ingredients: N-(Carbonyl-Methoxypolyethylene Glycol 2000)-1, 2-Distearoyl-Sn-Glycero-3-Phosphoethanolamine, Sodium Salt; Fully hydrogenated soy phosphatidylcholine (HSPC); Cholesterol; Ammonium sulphate; Sucrose; Histidine; Water for injections; Hydrochloric acid; Sodium hydroxide.
Other Services
Country
Account